NASDAQ · LQDA
Liquidia Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LQDA: Nov 2, 2026
Liquidia Corporation Common Stock is estimated to report earnings on 11/02/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.77. The reported EPS for the same quarter last year was $-0.04.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.77 | $0.78 | $0.76 | 2 |
| Dec 2026 | $0.11 | $0.70 | $-0.47 | 2 |
| Mar 2027 | $0.14 | $0.14 | $0.14 | 1 |
| Jun 2027 | $0.31 | $0.31 | $0.31 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · Barchart · BNK Invest- Zacks · Oct 29, 6:05 PM EDTStoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue EstimatesStoke Therapeutics (STOK) delivered earnings and revenue surprises of -22.73% and +35.88%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 28, 10:50 AM EDTLiquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?LQDA's Q3 results will spotlight the impact of its legal settlement with UTHR, cash flow pressures, profitability prospects and pipeline progress.
- Zacks · Oct 28, 9:00 AM EDTEyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?EyePoint (EYPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 26, 9:00 AM EDTLiquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?Liquidia Corporation (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Fintel · Oct 15, 4:50 PM EDTLifeSci Capital Upgrades Liquidia to Outperform from Market PerformFintel reports that on October 14, 2026, LifeSci Capital upgraded their outlook for Liquidia (NASDAQCM:LQDA) (MUN:LT4) from Market Perform to Outperform.LifeSci Capital previously downgraded Liquidia from Outperform to Market Perform on August 12, 2026. This upgrade on October 14
- Barchart · Oct 15, 1:56 PM EDTStocks Sharply Lower on Inflation Woes and Slumping ChipmakersThe S&P 500 Index ($SPX ) (SPY ) closed down by -1.11% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.02%. December E-mini S&P futures (ESZ26 ) fell -1.16%, and December E-mini…
- Barchart · Oct 14, 7:04 PM EDTStocks and Bonds Fall on a Strong CPI ReportThe S&P 500 Index ($SPX ) (SPY ) is down by -0.75% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.11%. December E-mini S&P futures (ESZ26 ) are down -0.80%, and December E-mini…
- Barchart · Oct 14, 5:49 PM EDTStocks Retreat on Sticky US Price PressuresThe S&P 500 Index ($SPX ) (SPY ) is down by -0.42% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.70%. December E-mini S&P futures (ESZ26 ) are down -0.61%, and December E-mini…
- Fintel · Oct 14, 4:16 PM EDTBTIG Upgrades Liquidia to Buy from NeutralFintel reports that on October 14, 2026, BTIG upgraded their outlook for Liquidia (NASDAQCM:LQDA) (MUN:LT4) from Neutral to Buy.This rating action follows a prior action by BTIG on October 1, 2026, when the firm downgraded the stock from Buy to Neutral. On the same day as the upg
- BNK Invest · Oct 14, 3:21 PM EDTNotable Wednesday Option Activity: NN, VRT, LQDAAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in NextNav Inc (Symbol: NN), where a total of 32,142 contracts have traded so far, representing approximately 3.2 million underlying shares. That amounts to about 102.9% of
- Zacks · Oct 14, 12:38 PM EDTLQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia LabelLiquidia settles six legal disputes with United Therapeutics, securing Yutrepia access for PAH patients but facing $380.7 million in payments and a narrower drug label.
- RTTNews · Oct 14, 2:25 AM EDTLiquidia Settles All Litigation With United Therapeutics; Shares Rise(RTTNews) – Liquidia Corp. (LQDA), a biopharmaceutical company, announced that it has entered into a global settlement agreement with United Therapeutics Corp. (UTHR) resolving all six pending litigation matters between the companies.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Liquidia Corporation from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.